Analysts Set Insulet Co. (NASDAQ:PODD) Price Target at $267.44

Dec 22, 2024 · Insulet Co. (NASDAQ:PODD – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the fifteen analysts that are presently covering the …

$267.44
OFF

Analysts Set Insulet Co. (NASDAQ:PODD) Price Target At $267.44

2 weeks from now

Dec 22, 2024 · Insulet Co. (NASDAQ:PODD – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the fifteen analysts that are presently covering the …

americanbankingnews.com

$272.81
OFF

Insulet (PODD) Stock Forecast And Price Target 2025 - MarketBeat

2 weeks from now

2 days ago · According to the 16 analysts' twelve-month price targets for Insulet, the average price target is $272.81. The highest price target for PODD is $330.00, while the lowest price …

marketbeat.com

41%
OFF

Insulet Corporation (PODD) Stock Forecast & Price Targets - Stock …

2 weeks from now

3 days ago · NASDAQ: PODD · Real-Time Price · USD. Watchlist Compare. 267.99-3.84 (-1.41%) At close: Jan 13, 2025, 4:00 PM. ... Analyst Ratings; Insulet Stock Forecast. All …

stockanalysis.com

$300.00
OFF

Insulet Co. (NASDAQ:PODD) Receives Average Recommendation …

2 weeks from now

3 days ago · Sanford C. Bernstein initiated coverage on shares of Insulet in a research note on Wednesday, November 6th. They set an "outperform" rating and a $300.00 target price for the …

marketbeat.com

$300.00
OFF

Insulet Co. (NASDAQ:PODD) Given Average Rating Of ... - MarketBeat

2 weeks from now

Dec 19, 2024 · Sanford C. Bernstein started coverage on Insulet in a research report on Wednesday, November 6th. They set an "outperform" rating and a $300.00 price target for the …

marketbeat.com

$260.22
OFF

9 Analysts Have This To Say About Insulet - Nasdaq

2 weeks from now

Nov 6, 2024 · The 12-month price targets, analyzed by analysts, offer insights with an average target of $260.22, a high estimate of $300.00, and a low estimate of $220.00.

nasdaq.com

$296.90
OFF

What Is The Current Price Target And Forecast For Insulet (PODD)

2 weeks from now

1 day ago · Based on short-term price targets offered by 20 analysts, the average price target for Insulet comes to $296.90. The forecasts range from a low of $234.00 to a high of $340.00.

zacks.com

$324.00
OFF

Insulet (NASDAQ:PODD) Stock, Analyst Ratings, Price Targets

2 weeks from now

The latest price target for Insulet (NASDAQ:PODD) was reported by TD Cowen on January 3, 2025. The analyst firm set a price target for $324.00 expecting PODD to rise to within 12 …

benzinga.com

$232
OFF

The Latest Analyst Ratings For Insulet - Nasdaq

2 weeks from now

Aug 12, 2024 · 5 analysts have shared their evaluations of Insulet (NASDAQ:PODD) ... The 12-month price targets, analyzed by analysts, offer insights with an average target of $232.4, a …

nasdaq.com

$279.91
OFF

Decoding 11 Analyst Evaluations For Insulet - Nasdaq

2 weeks from now

Dec 11, 2024 · 11 analysts have shared their evaluations of Insulet (NASDAQ:PODD) ... The 12-month price targets, analyzed by analysts, offer insights with an average target of $279.91, a …

nasdaq.com

$280.00
OFF

Insulet (PODD) – Investment Analysts’ Weekly Ratings Changes

2 weeks from now

12/12/2024 – Insulet had its price target raised by analysts at JPMorgan Chase & Co. from $280.00 to $330.00. They now have an “overweight” rating on the stock.

etfdailynews.com

14%
OFF

Insulin Device Maker Has Analysts Turning Bullish - Investor's …

2 weeks from now

Jan 7, 2025 · Analysts polled by FactSet see sales growth continuing into the fourth quarter with a 14% growth estimate or $582.5 million in sales. IBD Stock Of The Day Analysts Raise Price …

investors.com

$225.14
OFF

A Closer Look At 7 Analyst Recommendations For Insulet

2 weeks from now

Jul 23, 2024 · Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $225.14, along with a high estimate of $260.00 and a low …

nasdaq.com

$280.00
OFF

Insulet (NASDAQ:PODD) Stock Price Expected To Rise, TD Cowen …

2 weeks from now

Jan 3, 2025 · JPMorgan Chase & Co. lifted their price target on shares of Insulet from $280.00 to $330.00 and gave the stock an "overweight" rating in a report on Thursday, December 12th. …

marketbeat.com

$317
OFF

Are Wall Street Analysts Predicting Insulet Stock Will Climb

2 weeks from now

Nov 27, 2024 · On Nov. 12, Morgan Stanley raised Insulet's price target to $317 - the Street-high price target, maintaining an “Overweight” rating due to strong Q3 results, high-quality growth, …

nasdaq.com

$324
OFF

Insulet : 2025 JPM Healthcare Conference Presentation

2 weeks from now

9 hours ago · TD Cowen Adjusts Price Target on Insulet to $324 From $264, Keeps Buy Rating Jan. 03: MT Analyst recommendations: Block, JPMorgan Chase, Tesla, Shell, Polaris... Jan. …

marketscreener.com

$324.00
OFF

TD Cowen Boosts Insulet (NASDAQ:PODD) Price Target To $324.00

2 weeks from now

Jan 5, 2025 · Insulet (NASDAQ:PODD – Get Free Report) had its target price increased by investment analysts at TD Cowen from $264.00 to $324.00 in a research note issued to …

etfdailynews.com

$250.75
OFF

Insulet Corp Reaches Analyst Target Price - Nasdaq

2 weeks from now

Nov 11, 2024 · In recent trading, shares of Insulet Corp (Symbol: PODD) have crossed above the average analyst 12-month target price of $250.75, changing hands for $268.00/share. When a …

nasdaq.com

$324
OFF

Insulet Price Target Raised To $324 From $264 At TD Cowen

2 weeks from now

Jan 3, 2025 · TD Cowen raised the firm’s price target on Insulet (PODD) to $324 from $264 and keeps a Buy rating on the shares. The firm thinks Insulet will continue to deliver "beat-and …

nasdaq.com

FAQs about Analysts Set Insulet Co. (NASDAQ:PODD) Price Target at $267.44 Coupon?

Is Insulet a good stock to buy?

BTIG Research raised their target price on shares of Insulet from $260.00 to $270.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Sanford C. Bernstein initiated coverage on shares of Insulet in a research note on Wednesday, November 6th. They set an “outperform” rating and a $300.00 target price for the company. ...

Should you buy Insulet co (Podd) stock?

Shares of Insulet Co. (NASDAQ:PODD – Get Free Report) have received a consensus rating of “Moderate Buy” from the sixteen analysts that are currently covering the firm, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. ...

Is Insulet Corp (Podd) stock trading above its 200 day moving average?

I n trading on Tuesday, shares of Insulet Corp (Symbol: PODD) crossed above their 200 day moving average of $251.01, changing hands as high as $252.63 per share. Insulet Corp shares are currently trading up about 2% on the day. The chart below shows the one year performance of PODD shares, versus its 200 day moving average: ...

How do I receive news & ratings for Insulet co?

Receive News & Ratings for Insulet Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Insulet Co and related companies with MarketBeat.com's FREE daily email newsletter. ...

Do insiders own Insulet?

Company insiders own 0.47% of the company’s stock. A number of institutional investors have recently bought and sold shares of the stock. Blue Trust Inc. increased its position in shares of Insulet by 84.1% during the 3rd quarter. ...

How many analysts have rated equities research stock?

Three equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $272.81. ...